7 beta-hydroperoxycholest-5-en-3 beta-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein
- PMID: 7972083
- PMCID: PMC45249
- DOI: 10.1073/pnas.91.24.11452
7 beta-hydroperoxycholest-5-en-3 beta-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein
Abstract
Modification of low density lipoprotein (LDL) by free radical oxidation renders this molecular complex cytotoxic. Oxidized lipoproteins exist in vivo in atherosclerotic lesions and in the plasma of diabetic animals, suggesting that lipoprotein-induced tissue damage may occur in certain diseases. We undertook purification and identification of the major cytotoxin in oxidized LDL. The lipid extract from oxidized LDL was subjected to multiple HPLC separations, and the fractions were assayed for cytotoxicity. Mass spectrometry and nuclear magnetic resonance identified the purified toxin as 7 beta-hydroperoxycholest-5-en-3 beta-ol (7 beta-OOH-Chol). This molecule accounted for approximately 90% of the cytotoxicity of the lipids of oxidized LDL. We also found 7 beta-OOH-Chol in human atherosclerotic lesions from endarterectomy specimens obtained immediately after excision. These results are consistent with the hypothesis that the oxidized LDL present in lesions has the capacity to induce cell and tissue injury, leading to progression of the disease and the generation of the necrotic core of the lesion.
Similar articles
-
Evidence for the presence of 7-hydroperoxycholest-5-en-3 beta-ol in oxidized human LDL.Chem Phys Lipids. 1992 Oct;62(3):209-14. doi: 10.1016/0009-3084(92)90057-v. Chem Phys Lipids. 1992. PMID: 1468120
-
In vitro cell injury by oxidized low density lipoprotein involves lipid hydroperoxide-induced formation of alkoxyl, lipid, and peroxyl radicals.J Clin Invest. 1995 Oct;96(4):1866-73. doi: 10.1172/JCI118232. J Clin Invest. 1995. PMID: 7560078 Free PMC article.
-
7-Hydroperoxycholesterol and its products in oxidized low density lipoprotein and human atherosclerotic plaque.J Lipid Res. 1997 Sep;38(9):1730-45. J Lipid Res. 1997. PMID: 9323583
-
Oxidation of lipoproteins and atherosclerosis.Am J Clin Nutr. 1991 Jan;53(1 Suppl):206S-209S. doi: 10.1093/ajcn/53.1.206S. Am J Clin Nutr. 1991. PMID: 1985389 Review.
-
Bioactive products of phospholipid oxidation: isolation, identification, measurement and activities.Free Radic Biol Med. 2000 Jun 15;28(12):1751-61. doi: 10.1016/s0891-5849(00)00233-1. Free Radic Biol Med. 2000. PMID: 10946217 Review.
Cited by
-
Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.J Clin Invest. 1996 Aug 1;98(3):800-14. doi: 10.1172/JCI118853. J Clin Invest. 1996. PMID: 8698873 Free PMC article.
-
AM-251 and SR144528 are acyl CoA:cholesterol acyltransferase inhibitors.Biochem Biophys Res Commun. 2009 Apr 3;381(2):181-6. doi: 10.1016/j.bbrc.2009.02.020. Epub 2009 Feb 11. Biochem Biophys Res Commun. 2009. PMID: 19338772 Free PMC article.
-
Review of progress in sterol oxidations: 1987-1995.Lipids. 1996 May;31(5):453-87. doi: 10.1007/BF02522641. Lipids. 1996. PMID: 8727640 Review.
-
Evaluating oxidative stress in human cardiovascular disease: methodological aspects and considerations.Curr Med Chem. 2012;19(16):2504-20. doi: 10.2174/092986712800493057. Curr Med Chem. 2012. PMID: 22489713 Free PMC article. Review.
-
Do oxysterols control cholesterol homeostasis?J Clin Invest. 2002 Sep;110(6):725-30. doi: 10.1172/JCI16388. J Clin Invest. 2002. PMID: 12235099 Free PMC article. Review. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials